4.6 Article

Nonalcoholic fatty liver disease and HFE gene mutations: A Polish study

Journal

WORLD JOURNAL OF GASTROENTEROLOGY
Volume 16, Issue 20, Pages 2531-2536

Publisher

BAISHIDENG PUBLISHING GROUP INC
DOI: 10.3748/wjg.v16.i20.2531

Keywords

Nonalcoholic fatty liver disease; HFE gene mutations; Liver fibrosis

Funding

  1. State Committee for Scientific Research [N 402 099 21/3037]

Ask authors/readers for more resources

AIM: To describe a Polish population with nonalcoholic fatty liver disease (NAFLD) with regard to HFE gene mutations, as well as analyzing demographic and clinical data. METHODS: Sixty-two consecutive patients with biopsy-proven NAFLD were included in the study. Demographic, clinical, and laboratory data were summarized in a database. C282Y and H63D mutations of the HFE gene were analyzed using polymerase chain reaction-restriction fragment lenght polymorphism. RESULTS: The analyzed cohort consisted of 62 homogeneic Caucasian participants, 66.1% men and 33.9% women, with a median age of 48 years. The median body mass index was 29.05 kg/m(2). Hypercholesterolemia was observed in 74.2% of patients and hyper-triglyceridemia in 32.2%; 16.1% had type 2 diabetes mellitus (DMt2). On liver biopsy, 22.6% of NAFLD patients were found to have severe fibrosis. There were no differences between frequencies of HFE gene mutations in subgroups of NAFLD patients with less and more severe liver fibrosis. Obesity, older age, female gender and DMt2 were associated with more advanced fibrosis in this Polish cohort, as well as higher glucose level, serum iron and transaminase aspartate amino-transferase/alanine aminotransferase ratio. CONCLUSION: HFE mutations conferred no additional hepatic fibrosis risk in NAFLD, but higher serum iron was a risk factor for severe liver damage in NAFLD, regardless of HFE mutations. (C) 2010 Baishideng. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Blood arsenic levels and the risk of familial breast cancer in Poland

Wojciech Marciniak, Roza Derkacz, Magdalena Muszynska, Piotr Baszuk, Jacek Gronwald, Tomasz Huzarski, Cezary Cybulski, Anna Jakubowska, Michal Falco, Tadeusz Debniak, Marcin Lener, Oleg Oszurek, Katherine Pullella, Joanne Kotsopoulos, Ping Sun, Steven A. Narod, Jan Lubinski

INTERNATIONAL JOURNAL OF CANCER (2020)

Article Urology & Nephrology

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

Elizabeth C. Page, Elizabeth K. Bancroft, Mark N. Brook, Melissa Assel, Mona Hassan Al Battat, Sarah Thomas, Natalie Taylor, Anthony Chamberlain, Jennifer Pope, Holly Ni Raghallaigh, D. Gareth Evans, Jeanette Rothwell, Lovise Maehle, Eli Marie Grindedal, Paul James, Lyon Mascarenhas, Joanne McKinley, Lucy Side, Tessy Thomas, Christi van Asperen, Hans Vasen, Lambertus A. Kiemeney, Janneke Ringelberg, Thomas Dyrso Jensen, Palle J. S. Osther, Brian T. Helfand, Elena Genova, Rogier A. Oldenburg, Cezary Cybulski, Dominika Wokolorczyk, Kai-Ren Ong, Camilla Huber, Jimmy Lam, Louise Taylor, Monica Salinas, Lidia Feliubadalo, Jan C. Oosterwijk, Wendy van Zelst-Stams, Jackie Cook, Derek J. Rosario, Susan Domchek, Jacquelyn Powers, Saundra Buys, Karen O'Toole, Margreet G. E. M. Ausems, Rita K. Schmutzler, Kerstin Rhiem, Louise Izatt, Vishakha Tripathi, Manuel R. Teixeira, Marta Cardoso, William D. Foulkes, Armen Aprikian, Heleen van Randeraad, Rosemarie Davidson, Mark Longmuir, Marielle W. G. Ruijs, Apollonia T. J. M. Helderman van den Enden, Muriel Adank, Rachel Williams, Lesley Andrews, Declan G. Murphy, Dorothy Halliday, Lisa Walker, Annelie Liljegren, Stefan Carlsson, Ashraf Azzabi, Irene Jobson, Catherine Morton, Kylie Shackleton, Katie Snape, Helen Hanson, Marion Harris, Marc Tischkowitz, Amy Taylor, Judy Kirk, Rachel Susman, Rakefet Chen-Shtoyerman, Allan Spigelman, Nicholas Pachter, Munaza Ahmed, Teresa Ramon y Cajal, Janez Zgajnar, Carole Brewer, Neus Gadea, Angela F. Brady, Theo van Os, David Gallagher, Oskar Johannsson, Alan Donaldson, Julian Barwell, Nicola Nicolai, Eitan Friedman, Elias Obeid, Lynn Greenhalgh, Vedang Murthy, Lucia Copakova, Sibel Saya, John McGrath, Peter Cooke, Karina Ronlund, Kate Richardson, Alex Henderson, Soo H. Teo, Banu Arun, Karin Kast, Alexander Dias, Neil K. Aaronson, Audrey Ardern-Jones, Chris H. Bangma, Elena Castro, David Dearnaley, Diana M. Eccles, Karen Tricker, Jorunn Eyfjord, Alison Falconer, Christopher Foster, Henrik Gronberg, Freddie C. Hamdy, Vigdis Stefansdottir, Vincent Khoo, Geoffrey J. Lindeman, Jan Lubinski, Karol Axcrona, Christos Mikropoulos, Anita Mitra, Clare Moynihan, Gadi Rennert, Mohnish Suri, Penny Wilson, Tim Dudderidge, Judith Offman, Zsofia Kote-Jarai, Andrew Vickers, Hans Lilja, Rosalind A. Eeles

EUROPEAN UROLOGY (2019)

Article Oncology

A comparison of ovarian cancer mortality in women with BRCA1 mutations undergoing annual ultrasound screening or preventive oophorectomy

Jacek Gronwald, Jan Lubinski, Tomasz Huzarski, Cezary Cybulski, Janusz Menkiszak, Monika Siolek, Malgorzata Stawicka, Ping Sun, Shana J. Kim, Joanne Kotsopoulos, Steven A. Narod

GYNECOLOGIC ONCOLOGY (2019)

Article Clinical Neurology

Overlapping genetic architecture between Parkinson disease and melanoma

Umber Dube, Laura Ibanez, John P. Budde, Bruno A. Benitez, Albert A. Davis, Oscar Harari, Mark M. Iles, Matthew H. Law, Kevin M. Brown, Michelle Agee, Babak Alipanahi, Adam Auton, Robert K. Bell, Katarzyna Bryc, Sarah L. Elson, Pierre Fontanillas, Nicholas A. Furlotte, David A. Hinds, Karen E. Huber, Aaron Kleinman, Nadia K. Litterman, Jennifer C. McCreight, Matthew H. McIntyre, Joanna L. Mountain, Elizabeth S. Noblin, Carrie A. M. Northover, Steven J. Pitts, J. Fah Sathirapongsasuti, Olga V. Sazonova, Janie F. Shelton, Suyash Shringarpure, Chao Tian, Joyce Y. Tung, Vladimir Vacic, Catherine H. Wilson, M. H. Law, M. H. Law, D. T. Bishop, J. E. Lee, M. Brossard, N. G. Martin, E. K. Moses, F. Song, J. H. Barrett, R. Kumar, D. F. Easton, P. D. Pharoah, A. J. Swerdlow, K. P. Kypreou, J. C. Taylor, M. Harland, J. Randerson-Moor, L. A. Akslen, P. A. Andresen, M. F. Avril, E. Azizi, G. B. Scarra, K. M. Brown, T. Debniak, D. L. Duffy, D. E. Elder, S. Fang, E. Friedman, P. Galan, P. Ghiorzo, E. M. Gillanders, A. M. Goldstein, N. A. Gruis, J. Hansson, P. Helsing, M. Hocevar, V. Hoiom, C. Ingvar, P. A. Kanetsky, W. V. Chen, M. T. Landi, J. Lang, G. M. Lathrop, J. Lubinski, R. M. Mackie, G. J. Mann, A. Molven, G. W. Montgomery, S. Novakovic, H. Olsson, S. Puig, J. A. Puig-Butille, W. Wu, A. A. Qureshi, G. L. Radford-Smith, N. Van der Stoep, R. Van Doorn, D. C. Whiteman, J. E. Craig, E. Schadendorf, L. A. Simms, K. P. Burdon, D. R. Nyholt, K. A. Pooley, N. Orr, A. J. Stratigos, A. E. Cust, S. V. Ward, N. K. Hayward, J. Han, H. J. Schulze, A. M. Dunning, J. A. Bishop, F. Demenais, C. I. Amos, S. MacGregor, M. M. Iles, Carlos Cruchaga

ACTA NEUROPATHOLOGICA (2020)

Correction Clinical Neurology

Overlapping genetic architecture between Parkinson disease and melanoma (vol 139, pg 347, 2020)

Umber Dube, Laura Ibanez, John P. Budde, Bruno A. Benitez, Albert A. Davis, Oscar Harari, Mark M. Iles, Matthew H. Law, Kevin M. Brown, Carlos Cruchaga

ACTA NEUROPATHOLOGICA (2020)

Article Biochemistry & Molecular Biology

Influence of the Levels of Arsenic, Cadmium, Mercury and Lead on Overall Survival in Lung Cancer

Sandra Pietrzak, Janusz Wojcik, Piotr Baszuk, Wojciech Marciniak, Malgorzata Wojtys, Tadeusz Debniak, Cezary Cybulski, Jacek Gronwald, Jacek Alchimowicz, Bartlomiej Masojc, Piotr Waloszczyk, Darko Gajic, Tomasz Grodzki, Anna Jakubowska, Rodney J. Scott, Jan Lubinski, Marcin R. Lener

Summary: This study examined the relationship between blood concentrations of heavy metals and overall survival in lung cancer patients, finding that low blood cadmium levels may be associated with improved overall survival in treated patients with lung cancer.

BIOMOLECULES (2021)

Article Biochemistry & Molecular Biology

Survival of Laryngeal Cancer Patients Depending on Zinc Serum Level and Oxidative Stress Genotypes

Jakub Lubinski, Ewa Jaworowska, Roza Derkacz, Wojciech Marciniak, Katarzyna Bialkowska, Piotr Baszuk, Rodney J. Scott, Jan A. Lubinski

Summary: The study revealed that serum zinc levels were correlated with the survival of patients with laryngeal cancer, with higher zinc levels potentially improving survival rates. Additionally, the impact of serum zinc levels on survival was more significant in variants of the antioxidant enzymes SOD2 and CAT.

BIOMOLECULES (2021)

Article Biochemistry & Molecular Biology

Serum Selenium Level and 10-Year Survival after Melanoma

Emilia Rogoza-Janiszewska, Karolina Malinska, Piotr Baszuk, Wojciech Marciniak, Roza Derkacz, Marcin Lener, Anna Jakubowska, Cezary Cybulski, Tomasz Huzarski, Bartlomiej Masojc, Jacek Gronwald, Helena Rudnicka, Andrzej Kram, Magdalena Kiedrowicz, Magdalena Boer, Tadeusz Debniak, Jan Lubinski

Summary: The study found that patients with low serum selenium levels had a higher mortality rate in the 10 years following melanoma diagnosis compared to patients with high selenium levels. Future studies in regions with low soil selenium levels are needed to confirm these findings.

BIOMEDICINES (2021)

Article Biochemistry & Molecular Biology

Low Blood-As Levels and Selected Genotypes Appears to Be Promising Biomarkers for Occurrence of Colorectal Cancer in Women

Piotr Baszuk, Paulina Stadnik, Wojciech Marciniak, Roza Derkacz, Anna Jakubowska, Cezary Cybulski, Tomasz Huzarski, Jacek Gronwald, Tadeusz Debniak, Katarzyna Bialkowska, Sandra Pietrzak, Jozef Kladny, Rodney J. Scott, Jan Lubinski, Marcin R. Lener

Summary: The study showed that low blood arsenic levels are significantly associated with increased occurrence of colorectal cancer, and specific gene variants can enhance this correlation. Further validation is needed before definitively stating that the combined effect of low blood arsenic levels with specific gene polymorphisms is a suitable colorectal cancer biomarker.

BIOMEDICINES (2021)

Article Oncology

Do BARD1 Mutations Confer an Elevated Risk of Prostate Cancer?

Klaudia Stempa, Dominika Wokolorczyk, Wojciech Kluzniak, Emilia Rogoza-Janiszewska, Karolina Malinska, Helena Rudnicka, Tomasz Huzarski, Jacek Gronwald, Katarzyna Gliniewicz, Tadeusz Debniak, Anna Jakubowska, Marcin Lener, Joanna Tomiczek-Szwiec, Pawel Domagala, Malwina Suszynska, Piotr Kozlowski, Tomasz Kluz, Mariusz Naczk, Jan Lubinski, Steven A. Narod, Mohammad R. Akbari, Cezary Cybulski

Summary: The study found that mutations in the BARD1 gene do not increase the risk of prostate cancer or influence its characteristics or survival. However, BARD1 is a breast cancer predisposition gene, and female relatives of men with BARD1 mutations may benefit from this information.

CANCERS (2021)

Article Oncology

Risk of Second Primary Thyroid Cancer in Women with Breast Cancer

Monika Cieszynska, Wojciech Kluzniak, Dominika Wokolorczyk, Cezary Cybulski, Tomasz Huzarski, Jacek Gronwald, Michal Falco, Tadeusz Debniak, Anna Jakubowska, Roza Derkacz, Wojciech Marciniak, Marcin Lener, Karolina Woronko, Dominika Mocarz, Piotr Baszuk, Marta Bryskiewicz, Steven A. Narod, Jan Lubinski

Summary: This study aimed to evaluate the risk of developing thyroid cancer after a diagnosis of breast cancer and identify therapeutic and genetic risk factors. The findings showed that women carrying a CHEK2 mutation had a higher risk of thyroid cancer.

CANCERS (2022)

Article Biochemistry & Molecular Biology

Blood Copper Levels and the Occurrence of Colorectal Cancer in Poland

Piotr Baszuk, Wojciech Marciniak, Roza Derkacz, Anna Jakubowska, Cezary Cybulski, Jacek Gronwald, Tadeusz Debniak, Tomasz Huzarski, Katarzyna Bialkowska, Sandra Pietrzak, Magdalena Muszynska, Jozef Kladny, Steven A. Narod, Jan Lubinski, Marcin R. Lener

Summary: This study found that a high blood copper level is associated with an increased risk of colorectal cancer, especially for early-stage colon cancer, suggesting its potential use as a biomarker in early detection programs.

BIOMEDICINES (2021)

Article Nutrition & Dietetics

An Assessment of Serum Selenium Concentration in Women with Endometrial Cancer

Magdalena Janowska, Natalia Potocka, Sylwia Paszek, Marzena Skrzypa, Andrzej Wrobel, Marta Kluz, Piotr Baszuk, Wojciech Marciniak, Jacek Gronwald, Jan Lubinski, Izabela Zawlik, Tomasz Kluz

Summary: This study found a correlation between serum selenium levels and an increased risk of endometrial cancer, indicating that patients with low selenium levels should undergo appropriate preventive examinations.

NUTRIENTS (2022)

Article Oncology

Prevalence and spectrum of MLH1, MSH2, and MSH6 pathogenic germline variants in Pakistani colorectal cancer patients

Muhammad Usman Rashid, Humaira Naeemi, Noor Muhammad, Asif Loya, Jan Lubinski, Anna Jakubowska, Muhammed Aasim Yusuf

HEREDITARY CANCER IN CLINICAL PRACTICE (2019)

No Data Available